Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Total Debt of $752.59 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 14.0% from $659.93 million a year earlier but down 4.0% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories reported Total Debt of $819.67 million, up 49.8% from FY2025.

  • Annual Total Debt has increased for three straight fiscal years, with a five-year compound annual growth rate of 14.6% (FY2021 to FY2026).
  • Across earlier fiscal years, Total Debt came in at $547 million in FY2025 (+127.0%), $241 million in FY2024 (+47.0%), $164 million in FY2023 (-63.2%) and $446 million in FY2022 (+7.7%).
  • Quarterly Total Debt has ranged from $164.09 million in fiscal Q4 2023 to $819.67 million in fiscal Q4 2026 over the past five years.
  • On a year-over-year basis, Total Debt has increased for 11 consecutive quarters, with growth averaging 58.2% over the last eight quarters.
  • Peak year-over-year performance for Total Debt in the last five years was growth of 230.9% in fiscal Q2 2025, against a decline of 63.2% in fiscal Q4 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $784.17 million (Q1 2027), $819.67 million (Q4 2026) and $819.54 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 44.65 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 80.90 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -11.96 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 62.67 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 752.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 752.59 Mn
Jun 30, 2026 784.17 Mn
Mar 31, 2026 819.67 Mn
Dec 31, 2025 819.54 Mn
Sep 30, 2025 659.93 Mn
Jun 30, 2025 629.70 Mn
Mar 31, 2025 546.72 Mn
Dec 31, 2024 608.38 Mn
Sep 30, 2024 579.28 Mn
Jun 30, 2024 382.93 Mn
Mar 31, 2024 240.07 Mn
Dec 31, 2023 257.67 Mn
Sep 30, 2023 175.04 Mn
Jun 30, 2023 166.21 Mn
Mar 31, 2023 164.09 Mn
Dec 31, 2022 270.43 Mn
Sep 30, 2022 270.09 Mn
Jun 30, 2022 374.25 Mn
Mar 31, 2022 446.34 Mn
Dec 31, 2021 389.14 Mn
API Access

Dr Reddys Laboratories Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RDY&period=max&api_key=YOUR_API_KEY